474 related articles for article (PubMed ID: 15980234)
1. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2444-50. PubMed ID: 15980234
[TBL] [Abstract][Full Text] [Related]
2. In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells.
Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4594-9. PubMed ID: 16303954
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.
Baudouin C; Riancho L; Warnet JM; Brignole F
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4123-8. PubMed ID: 17724196
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.
Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
Curr Eye Res; 2008 Apr; 33(4):303-12. PubMed ID: 18398704
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.
Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
Curr Eye Res; 2011 Nov; 36(11):979-88. PubMed ID: 21999224
[TBL] [Abstract][Full Text] [Related]
7. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
[TBL] [Abstract][Full Text] [Related]
8. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions.
Liang H; Brignole-Baudouin F; Riancho L; Baudouin C
Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells.
De Saint Jean M; Brignole F; Feldmann G; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2199-212. PubMed ID: 10476784
[TBL] [Abstract][Full Text] [Related]
10. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C
J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334
[TBL] [Abstract][Full Text] [Related]
11. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study.
Pisella PJ; Debbasch C; Hamard P; Creuzot-Garcher C; Rat P; Brignole F; Baudouin C
Invest Ophthalmol Vis Sci; 2004 May; 45(5):1360-8. PubMed ID: 15111589
[TBL] [Abstract][Full Text] [Related]
12. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells.
De Saint Jean M; Brignole F; Bringuier AF; Bauchet A; Feldmann G; Baudouin C
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):619-30. PubMed ID: 10067965
[TBL] [Abstract][Full Text] [Related]
13. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears.
Kahook MY; Noecker RJ
Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment.
Rodrigues Mde L; Felipe Crosta DP; Soares CP; Deghaide NH; Duarte R; Sakamoto FS; Furtado JM; Paula JS; Donadi EA; Soares EG
J Glaucoma; 2009 Mar; 18(3):197-200. PubMed ID: 19295371
[TBL] [Abstract][Full Text] [Related]
15. Corneal epithelial cell viability following exposure to ophthalmic solutions containing preservatives and/or antihypertensive agents.
Whitson JT; Petroll WM
Adv Ther; 2012 Oct; 29(10):874-88. PubMed ID: 23065664
[TBL] [Abstract][Full Text] [Related]
16. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways.
Baudouin C; Liang H; Hamard P; Riancho L; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F
Ophthalmology; 2008 Jan; 115(1):109-15. PubMed ID: 17532048
[TBL] [Abstract][Full Text] [Related]
17. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
[TBL] [Abstract][Full Text] [Related]
18. [Toxicity of preserved and unpreserved beta-blocker eyedrops in an in vitro model of human conjunctival cells].
de Saint Jean M; Debbasch C; Brignole F; Rat P; Warnet JM; Baudouin C
J Fr Ophtalmol; 2000 Feb; 23(2):111-21. PubMed ID: 10705112
[TBL] [Abstract][Full Text] [Related]
19. [Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients].
Pisella PJ; Lala E; Parier V; Brignole F; Baudouin C
J Fr Ophtalmol; 2003 Sep; 26(7):675-9. PubMed ID: 13130254
[TBL] [Abstract][Full Text] [Related]
20. [Flow cytometric analysis of HLA-DR, IL-6 and IL-8 expression by conjunctival epithelial cells from patients with prolonged topical antiglaucoma treatments].
Bensoussan L; Blondin C; Baudouin C; Hamard P; Sabeh Afaki G; Creuzot-Garcher C; Warnet JM; Brignole-Baudouin F
J Fr Ophtalmol; 2003 Oct; 26(8):782-9. PubMed ID: 14586218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
